Epidiolex® for Anxiety in Pediatric Epilepsy
Clinical trial NCT05324449 · COMPLETED
Trial details
- NCT number
- NCT05324449
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2025-03-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.